Loading...
Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
Fluoroquinolones have been in clinical use for over 50 years with significant efficacy. However, increasing resistance and emergence of some marked adverse events have limited their usage. The most recently approved class member, delafloxacin, is the only available anionic (non-zwitterionic) fluoroq...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452001/ https://ncbi.nlm.nih.gov/pubmed/30957164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy1079 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|